Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
出版年份 2021 全文链接
标题
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
作者
关键词
-
出版物
JACC-Cardiovascular Imaging
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-01-15
DOI
10.1016/j.jcmg.2020.10.017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Left Ventricular Fibrosis in Middle-Age Athletes and Physically Active Adults
- (2020) Laura Banks et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial
- (2020) Erika Opingari et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance
- (2020) Mohammad A. Khan et al. Circulation-Cardiovascular Imaging
- Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
- (2019) Prathap Kanagala et al. JACC-Cardiovascular Imaging
- Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1
- (2019) Thomas A. Treibel et al. JACC-Cardiovascular Imaging
- Direct effects of empagliflozin on extracellular matrix remodeling in human cardiac myofibroblasts: Novel translational clues to EMPA-REG OUTCOME
- (2019) Sean Kang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Regression of Left Ventricular Mass in Athletes Undergoing Complete Detraining Is Mediated by Decrease in Intracellular but Not Extracellular Compartments
- (2019) Peter P. Swoboda et al. Circulation-Cardiovascular Imaging
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes
- (2019) Vinay Garg et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease
- (2019) C. David Mazer et al. CIRCULATION
- Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits
- (2019) Subodh Verma AMERICAN JOURNAL OF CARDIOLOGY
- Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis
- (2019) Eric Y. Yang et al. Circulation-Cardiovascular Imaging
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis
- (2018) Baiyan Zhuang et al. HEART FAILURE REVIEWS
- Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis
- (2018) Thomas A. Treibel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
- (2018) Thiago Ferreira de Souza et al. JACC-Cardiovascular Imaging
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy
- (2018) Tomas Vita et al. JACC-Cardiovascular Imaging
- Native T1 and Extracellular Volume Measurements by Cardiac MRI in Healthy Adults: A Meta-Analysis
- (2018) Matthew Gottbrecht et al. RADIOLOGY
- Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2016) Michael R. Zile et al. Circulation-Heart Failure
- Prognostic Value of Soluble ST2 in the Valsartan Heart Failure Trial
- (2014) Inder S. Anand et al. Circulation-Heart Failure
- Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission
- (2013) T. C. Wong et al. EUROPEAN HEART JOURNAL
- Myocardial Extracellular Volume Fraction From T1 Measurements in Healthy Volunteers and Mice
- (2013) Tomas G. Neilan et al. JACC-Cardiovascular Imaging
- CMR Quantification of Myocardial Scar Provides Additive Prognostic Information in Nonischemic Cardiomyopathy
- (2013) Tomas G. Neilan et al. JACC-Cardiovascular Imaging
- Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease
- (2012) Otavio R. Coelho-Filho et al. Circulation-Cardiovascular Imaging
- Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T 1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients
- (2011) Arnold C.T. Ng et al. Circulation-Cardiovascular Imaging
- Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance
- (2011) Andrew S. Flett et al. JACC-Cardiovascular Imaging
- Stress Myocardial Perfusion Imaging by CMR Provides Strong Prognostic Value to Cardiac Events Regardless of Patient's Sex
- (2011) Otavio R. Coelho-Filho et al. JACC-Cardiovascular Imaging
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started